Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a propensity score-matched analysis of two nationwide prospective cohort studies

Haruki Watanabe,Ken-ei Sada,Yoshinori Matsumoto,Masayoshi Harigai,Koichi Amano,Shouichi Fujimoto,Hiroaki Dobashi,Yukio Yuzawa,Kunihiro Yamagata,Eri Muso,Yoshihiro Arimura,Hirofumi Makino

Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a propensity score-matched analysis of two nationwide prospective cohort studies

2020

Haruki Watanabe
Ken-ei Sada
Yoshinori Matsumoto
Masayoshi Harigai
Koichi Amano
Shouichi Fujimoto
Hiroaki Dobashi
Yukio Yuzawa
Kunihiro Yamagata
Eri Muso
Yoshihiro Arimura
Hirofumi Makino

AbstractObjectives: We evaluated the effectiveness of cyclophosphamide for patients with microscopic polyangiitis and granulomatosis with polyangiitis.Methods: Patients treated with cyclophosphamid...

Keywords:

Prospective cohort study
Physical therapy
Gastroenterology
Granulomatosis with polyangiitis
Microscopic polyangiitis
Medicine
Vasculitis
Anti-neutrophil cytoplasmic antibody
Cyclophosphamide
Concomitant
Diabetes mellitus
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations